MEnstrual Cycle pHase ANd dIabeteS Management
- Conditions
- Type 1 Diabetes Mellitus
- Registration Number
- NCT07004504
- Lead Sponsor
- DCB Research AG
- Brief Summary
This study examines how menstrual cycle phases affect glycemic control and insulin requirements in women with type 1 diabetes (T1D). It aims to analyze differences in insulin needs and glucose levels between follicular and luteal phases using data from the Tidepool Data Platform. Key parameters include mean glucose, Time in Range (TIR), and total insulin administration. Secondary objectives involve assessing phase-specific glucose fluctuations, aggregated differences, and insulin adjustment strategies. The study follows a decentralized, anonymous data collection approach with participants using CGMs and insulin pumps or smart pens. Statistical analysis includes linear mixed-effects modeling to compare glycemic variability across cycle phases. Findings aim to enhance our understanding of diabetes management during the menstrual cycle and potentially inform future treatment strategies.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 77
Not provided
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mean glucose Between 1 and 12 months Mean daily glucose based on CGM data
- Secondary Outcome Measures
Name Time Method Time in range (TIR) Between 1 and 12 months Mean daily TIR based on CGM data
Time above range (TAR) Between 1 and 12 months Mean daily TAR based on CGM data
Time belwo range (TBR) Between 1 and 12 months Mean daily TBR based on CGM data
Total daily insulin Between 1 and 12 months Mean daily total insulin based on insulin pump data
Total basal insulin Between 1 and 12 months Mean daily total basal insulin based on insulin pump data
Total bolus insulin Between 1 and 12 months Mean daily total bolus insulin based on insulin pump data
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
DCB Research AG
🇨🇭Bern, Switzerland
DCB Research AG🇨🇭Bern, Switzerland